Table 2.
Comparison of characteristics between second-look endoscopy group and non-endoscopy group
| SLE group (n = 210) | Non-SLE group (n = 237) | P value | |
|---|---|---|---|
| Age (year, mean ± SD) |
71.5 ± 8.3 |
71.6 ± 9.2 |
0.892 (NS) |
| Gender Man/Woman |
163 (77.6%)/47 (22.4%) |
172 (72.6%)/65 (27.4%) |
0.263 (NS) |
| Tumor location |
|
|
|
| U |
30 (14.3%) |
45 (19.0%) |
0.315 (NS) |
| M |
79 (37.6%) |
97 (40.9%) |
0.537 (NS) |
| L |
101 (48.1%) |
95 (40.1%) |
0.108 (NS) |
| Macroscopic type |
|
|
|
| Elevated type/Depressed type |
115 (54.8%)/95 (45.2%) |
132 (55.7%)/105 (44.3%) |
0.918 (NS) |
| Tumor size |
|
|
|
| (mm, mean ± SD) |
16.5 ± 9.0 |
17.5 ± 11.8 |
0.309 (NS) |
| Histopathology |
|
|
|
| Adenoma/Carcinoma |
30 (14.3%)/180 (85.7%) |
41 (17.3%)/196 (82.7%) |
0.460 (NS) |
| Depth of invasion |
|
|
|
| M/SM |
189 (90.0%)/21 (10.0%) |
223 (94.1%)/14 (5.9%) |
0.152 (NS) |
| Heart disease |
35 (16.7%) |
34 (14.3%) |
0.584 (NS) |
| Renal disease |
7 (3.3%) |
14 (5.9%) |
0.289 (NS) |
| Hepatic disease |
23 (11.0%) |
19 (8.0%) |
0.368 (NS) |
| Pulmonary disease |
13 (6.2%) |
20 (8.4%) |
0.661 (NS) |
| Brain disease |
24 (11.4%) |
18 (7.6%) |
0.221 (NS) |
| Hypertension |
92 (43.8%) |
121 (51.1%) |
0.126 (NS) |
| Diabetes mellitus |
36 (17.1%) |
38 (6.0%) |
0.851 (NS) |
| Hyperlipidemia | 23 (11.0%) | 41 (17.3%) | 0.056 (NS) |